Connecting you to content on EBSCOhost

Works matching IS 20445385 AND DT 2022 AND VI 12 AND IP 7

Results: 8

1

BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 7, p. 1, doi. 10.1038/s41408-022-00704-7

By:

Weisberg, Ellen;
Chowdhury, Basudev;
Meng, Chengcheng;
Case, Abigail E.;
Ni, Wei;
Garg, Swati;
Sattler, Martin;
Azab, Abdel Kareem;
Sun, Jennifer;
Muz, Barbara;
Sanchez, Dana;
Toure, Anthia;
Stone, Richard M.;
Galinsky, Ilene;
Winer, Eric;
Gleim, Scott;
Gkountela, Sofia;
Kedves, Alexia;
Harrington, Edmund;
Abrams, Tinya

Publication type:

Article

2

G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial.

Published in:

2022

By:

Stopka, Tomáš;
Minařík, Lubomír;
Dusilková, Nina;
Pešta, Michal;
Kulvait, Vojtěch;
Špaček, Martin;
Zemanová, Zuzana;
Kalousová, Marta;
Jonášová, Anna

Publication type:

Letter

3

Racial differences as predictors of outcomes in young patients with multiple myeloma.

Published in:

2022

By:

Bao, Alicia;
Zhao, Qiuhong;
Merritt, Elizabeth;
Bumma, Naresh;
Devarakonda, Srinivas;
Khan, Abdullah M.;
Umyarova, Elvira;
Rosko, Ashley E.;
Benson, Don M.;
Cottini, Francesca

Publication type:

Letter

4

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.

Published in:

2022

By:

Alkhateeb, Hassan B.;
Mohty, Razan;
Greipp, Patricia;
Bansal, Radhika;
Hathcock, Matthew;
Rosenthal, Allison;
Murthy, Hemant;
Kharfan-Dabaja, Mohamed;
Bisneto Villasboas, Jose C.;
Bennani, Nora;
Ansell, Stephen M.;
Patnaik, Mrinal M.;
Litzow, Mark R.;
He, Rong;
Chen, Dong;
Al-Kali, Aref;
Kenderian, Saad S.;
Lin, Yi;
Shah, Mithun Vinod

Publication type:

Letter

5

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms.

Published in:

2022

By:

Gagnon, Marie-France;
Tian, Shulan;
Geyer, Susan;
Sharma, Neeraj;
Vachon, Celine M.;
Kusne, Yael;
Bergsagel, P. Leif;
Stewart, A. Keith;
Rajkumar, S. Vincent;
Kumar, Shaji;
Ailawadhi, Sikander;
Baughn, Linda B.

Publication type:

Letter

6

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant.

Published in:

2022

By:

Sora, Federica;
Giammarco, Sabrina;
Raiola, Anna Maria;
Di Grazia, Carmen;
Bregante, Stefania;
Gualandi, Francesca;
Varaldo, Riccardo;
Chiusolo, Patrizia;
Sica, Simona;
Laurenti, Luca;
Innocenti, Idanna;
Autore, Francesco;
Metafuni, Elisabetta;
Galli, Eugenio;
Bacigalupo, Andrea;
Angelucci, Emanuele

Publication type:

Letter

7

Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 7, p. 1, doi. 10.1038/s41408-022-00699-1

By:

Künstner, Axel;
Schwarting, Julian;
Witte, Hanno M.;
Bernard, Veronica;
Stölting, Stephanie;
Kusch, Kathrin;
Nagarathinam, Kumar;
von Bubnoff, Nikolas;
Murga Penas, Eva Maria;
Merz, Hartmut;
Busch, Hauke;
Feller, Alfred C.;
Gebauer, Niklas

Publication type:

Article

8

Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans.

Published in:

Blood Cancer Journal, 2022, v. 12, n. 7, p. 1, doi. 10.1038/s41408-022-00697-3

By:

Staron, Andrew;
Zheng, Luke;
Doros, Gheorghe;
Sanchorawala, Vaishali

Publication type:

Article